Nanalysis Scientific Corp.
NSCIF
$0.09
$0.015.88%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -10.76% | 0.16% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -10.76% | 0.16% | |||
| Cost of Revenue | -14.94% | 6.52% | |||
| Gross Profit | 3.67% | -16.93% | |||
| SG&A Expenses | -19.10% | 9.49% | |||
| Depreciation & Amortization | -3.36% | 65.42% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -15.05% | 11.64% | |||
| Operating Income | 67.32% | -381.14% | |||
| Income Before Tax | 45.68% | -67.12% | |||
| Income Tax Expenses | -157.86% | 343.48% | |||
| Earnings from Continuing Operations | 49.10% | -76.17% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 49.10% | -76.17% | |||
| EBIT | 67.32% | -381.14% | |||
| EBITDA | 180.66% | -256.88% | |||
| EPS Basic | 49.25% | -48.89% | |||
| Normalized Basic EPS | 46.34% | -355.56% | |||
| EPS Diluted | 52.78% | 0.00% | |||
| Normalized Diluted EPS | 46.34% | -355.56% | |||
| Average Basic Shares Outstanding | 1.20% | 16.77% | |||
| Average Diluted Shares Outstanding | 1.20% | 16.77% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||